A randomized, placebo-controlled study of the use of filgrastim in non neutropenic patients with nosocomial pneumonia.

@article{Hartmann2005ARP,
  title={A randomized, placebo-controlled study of the use of filgrastim in non neutropenic patients with nosocomial pneumonia.},
  author={Pia Hartmann and Jan Lammertink and Georg Mansmann and Kai H{\"u}bel and Bernd Salzberger and Hartmut Stuetzer and Andreas Engert and G F{\"a}tkenheuer},
  journal={European journal of medical research},
  year={2005},
  volume={10 1},
  pages={29-35}
}
Pneumonia remains the number one cause of death from infectious diseases in Western Europe and the United States despite the introduction of potent broad-spectrum antibiotics. Granulocyte colony-stimulating factor is considered to improve host defense during infection and may be an effective adjunctive in the treatment of severe infections. We examined the efficacy of granulocyte colony-stimulating factor (r-metHUG-CSF, filgrastim) with regard to clinical response in non-neutropenic ICU… CONTINUE READING